The Flow Stops Here - GEST 2022

Join Merit Medical for “The Flow Stops Here” at GEST 2022

The Flow Stops Here - GEST 2022Merit will be exhibiting at GEST 2022: Global Embolization Oncology Symposium Technologies. This year’s annual conference features an international audience with in-person training and hands-on workshops in New York, NY. Our theme for this year’s Symposium is The Flow Stops Here, a bold commitment to offering high-quality embolotherapy products and services designed to improve outcomes for physicians and their patients.

PRODUCT SHOWCASE AT BOOTH #801

Embosphere MicrospheresEmbosphere® Microspheres

The most clinically studied spherical embolic, Merit’s Embosphere Microspheres are the clear choice among interventional radiologists. Designed for predictable and durable occlusion for the embolization of symptomatic uterine fibroids, ABMs, and hypervascular tumors, the elastic material allows for temporary compression of up to 33%,1 yielding targeted results for patients and practitioners.

Embocube Embolization GelatinEmbocube® Embolization Gelatin

Specifically designed for embolization of hypervascular tumors and blood vessels to occlude blood flow, Embocube Embolization Gelatin consistently controls hemorrhaging in the peripheral vasculature. Gelatin is cut uniformly in preloaded 1-mL or 3-mL Medallion® Syringes to help ensure seamless prep and accurate delivery.

SwiftNINJASwiftNINJA® Steerable Microcatheter

The SwiftNINJA Steerable Microcatheter is an innovative straight-tip catheter featuring an ergonomic steering dial that navigates up to 180 degrees and enables in vivo control. Consisting of a hydrophilic-coated distal 80 cm, the device delivers exceptional precision and speed navigating even in the most challenging vascular ostium.


We look forward to seeing you at GEST 2022—where #TheFlowStopsHere!

Questions? Contact our Customer Support Center, and speak to one of our representatives via live chat, phone, or email.

Before using any of the Merit products mentioned above, refer to Instructions for Use for indications, contraindications, warnings, precautions, and directions for use.

REFERENCES

  1. Laurent et al. 1996. “Trisacryl Gelatin Microspheres for Therapeutic Embolization, I: Development and In Vitro Evaluation.” Am J Neuroradial 17:533-540
Distal Radial Access

“A Real Winning Combination”: Prelude IDeal™ and PreludeSYNC DISTAL™ Provide Complete Solution for Distal Radial Access

Distal Radial AccessDistal radial access has emerged as an accessible, optimal solution for physicians seeking to provide the greatest experience for their patients. While femoral and traditional radial access have previously been standard, distal radial offers additional advantages to both patient and operator. To support distal radial artery access, Merit offers a suite of products designed to minimize risk, maximize patient comfort, and provide ease of use for care teams to incorporate.

Ethan C. Korngold, MD, FSCAI - Distal Radial AccessWe spoke with Ethan C. Korngold, MD, FSCAI, interventional cardiologist at Providence St. Vincent Hospital in Portland, OR, to hear his experience choosing two Merit products in particular for his distal radial artery access procedures: the Prelude IDeal Hydrophilic Sheath Introducer and the PreludeSYNC DISTAL, a radial compression device specially created for the distal radial access site.

Why Distal Radial?

Literature shows that radial access provides multiple benefits, including less bleeding complications, decreased procedure cost, and enhanced sheath performance.1

According to Dr. Korngold, patients undergoing distal radial access interventions may experience additional advantages over radial access, including increased mobility post-procedure. “It is much less invasive than traditional radial access—my patients are able to resume normal activities much more quickly,” Dr. Korngold says. “Distal radial access may also lead to less occlusion of the radial artery. I think the important thing is that it preserves the radial artery should future interventions be necessary.”

Mitigating Risk

Prelude IDeal Sheath Introducer - Merit MedicalKinking and compressing are recognized challenges for operators when navigating catheters during radial access procedures.

“It’s very important when performing distal access to have a sheath that’s kink resistant. I really do prefer the kink resistance of the braided Prelude IDeal sheath. I also find it has impressive push forces; it’s a stronger, stiffer sheath that performs better than others I’ve used,” Dr. Korngold explains.

Merit designed the Prelude IDeal specifically to reduce the impact of these risks to patients. Composite braiding technology gives the Prelude IDeal sheath a 13% thinner wall than the leading competitor.2 With proprietary engineering, the sheath is thinner and stronger while achieving 124% increased compression resistance and 23% more kink resistance than the leading competitor.2

Prelude IDeal Compression & Kink Resistance Features

Dr. Korngold shares his firsthand experience with similar products. “I’ve used other non-braided sheaths, both slender and non-slender varieties. I found that even the non-slender varieties are just too prone to kinking. The kink resistance of the Prelude IDeal is excellent; it’s an essential feature for distal radial access.”

Maximizing Patient Comfort

PreludeSYNC DISTAL - Secure, Comfortable and EffectiveDr. Korngold has found that he’s received significantly fewer patient complaints of swelling, discomfort, or hematomas since opting for the PreludeSYNC DISTAL.

Constructed with soft material, the PreludeSYNC DISTAL provides comfortable wear. Its three-strap band configuration allows for an adjustable fit with optional extension if needed especially for larger hands. The PreludeSYNC DISTAL also delivers clear, unobstructed site visibility for focused compression. A built-in Slip-n-Lock™ Cap provides a specialized connection, securing syringes during inflation and deflation, supporting patient safety.

“The PreludeSYNC DISTAL band is really just perfectly designed. Everyone who does distal radial access has experimented with different ways of doing it. No solution is as efficient, convenient, or as comfortable for patients,” Dr. Korngold says.

Ease of Use

Medical devices must be effective, but equally important is ease of use. Dr. Korngold reports that incorporating the Prelude IDeal and PreludeSYNC DISTAL into his practice was seamless.

“It’s very easy to train the care team on how to use them properly,” he says, referring to his experience introducing both products to his staff. “Our nurses on the floor found it very intuitive and easy to manage. Both products fit perfectly into our existing workflows, so I’d say it’s a real winning combination.”

A Complete Solution

Merit is committed to developing tools that improve patient’s lives in partnership with the physicians who provide their care. The Prelude IDeal Hydrophilic Sheath Introducer and PreludeSYNC DISTAL are prime examples of this dedication and have become the go-to tools for distal radial access procedures around the globe.

Discover the Prelude IDeal Hydrophilic Sheath Introducer and the PreludeSYNC DISTAL, and live chat with our Customer Support team to see how you can incorporate them into your practice.


REFERENCES

  1. Rathore S et al. 2010. “Impact of Length and Hydrophilic Coating of the Introducer Sheath on Radial Artery Spasm During Transradial Coronary Intervention.” JACC 3, no. 5 (May): 475 ̶ 483. PMID: 20488402.
  2. 6F Data on File.
Merit Recognizes National Kidney Month

Merit Medical Recognizes National Kidney Month

Merit Recognizes National Kidney MonthMarch is National Kidney Month, and Merit Medical is committed to empowering the health and wellness of people living with chronic kidney disease and their caregivers. At Merit, our goal is to support the renal health community through a vast array of state-of-the-art therapeutic products, physician education courses, and patient education tools that equip clinicians to make a difference for people living with chronic kidney disease.

According to the National Institutes of Health, approximately 37 million Americans live with chronic kidney disease.1 Although incidences of chronic kidney disease have risen consistently, 9 out of 10 people are not aware of their diagnosis because early-stage kidney disease generally has no symptoms.1

The U.S. Renal Data System 2020 Annual Report cited that approximately 786,000 Americans live with end-stage renal or kidney disease, with 71% (558,000) of those receiving dialysis and 29% (228,000) receiving a kidney transplant.2 People living with end-stage kidney disease require dialysis therapy to regulate body functions, including controlling blood pressure, because their kidneys no longer can.3 Without access to adequate, regular, and affordable dialysis care, people living with end-stage kidney disease will not survive.3

As the number of people impacted by kidney disease continues to increase, Merit’s significant commitment to the renal health community is crucial. Merit is uniquely positioned with hemodialysis and peritoneal dialysis (PD) options for treatments and ancillary products that make a difference for dialysis patients who depend on high-quality care.


Merit Products

HeRO Graft - Hemodialysis Reliable Outflow

Super HeRO®

The Super HeRO Adapter and Support Seal system equips surgeons with standard wall and early cannulation vascular graft options. In addition to reducing hospital admissions due to catheter infections, the Super HeRO helps hospitals and dialysis centers save $3,100 per patient per year when converting catheter-dependent patients to the HeRO graft.

HeRO Graft - Hemodialysis Reliable Outflow

HeRO Graft®

For catheter-dependent patients, or those whose kidney function fails to improve with fistulas or grafts, Merit has engineered a solution: the HeRO Graft, a hemodialysis access graft designed precisely for these patients. Research indicated a 69% reduction in future infections with the HeRO Graft compared to patients receiving catheters.

Surfacer Now Available In the United States - Merit Medical

Surfacer® Inside-Out® Access Catheter System

The Inside-Out approach was developed by John Gurley, M.D., in response to patients with chronically occluded veins. The Surfacer Inside-Out Access Catheter System is inserted through the femoral vein and navigated to an exit point in the right internal jugular vein, preserving the viability of secondary central veins.

Home Dialysis Continues to Be a Nationwide Interest

Peritoneal Dialysis Catheters

To improve flow rates by 30%, Merit designed Flex-Neck Peritoneal Dialysis Catheters with an internal diameter (ID) that is 35% larger than competitors. Infant catheters come in one and two cuff configurations, and each catheter kit has a unique stenciling system for improved placement accuracy.

Centros® & CentrosFLO® Hemodialysis Catheters

CentrosFlo® Hemodialysis Catheters

Featuring self-centering curved tips to promote optimal blood flow and minimize recirculation rates, The Centros (without side holes) and the CentrosFLO™ (with side holes) long-term hemodialysis catheters reach the pinnacle of overall catheter performance. Designed by Dr. Stephen Ash, Merit’s 15F catheters feature a large internal lumen, promoting a flow rate up to 450 mL/minutes.

ProGuide™ Chronic Dialysis Catheters

ProGuide™ Chronic Dialysis Catheters

Designed for patient comfort, ease of insertion, and maintenance, ProGuide Chronic Dialysis Catheters are inserted through a valved peel-away sheath or over-the-wire placements and available in catheter lengths from 19 cm to 50 cm (tip to cuff). Available configurations include standalone catheter, basic kit, complete kit, and complete kit with mini access kit.


Physicians and surgeons look to Merit to provide insightful resources and cutting-edge therapeutic products designed to make a difference for people living with chronic kidney disease. Merit designs and innovates leading products specifically for patients receiving dialysis. For more information on how you can incorporate our biopsy products into your practice, please contact Merit Customer Support.


REFERENCES

  1. National Institutes of Health. National Kidney Month 2022. Retrieved from https://www.niddk.nih.gov/health-information/community-health-outreach/national-kidney-month
  2. American Society of Nephrology. (April 2021). Dialysis Care Around The World: A Global Perspective. Retrieved from https://kidney360.asnjournals.org/content/2/4/604
  3. National Kidney Foundation. Dialysis Info. Retrieved from https://www.kidney.org/atoz/content/dialysisinfo
The Solutions for Your Clinical Challenges - Merit Medical

What’s Your Clinical Challenge? We Have a Solution.

As a leader in customer-focused healthcare, Merit Medical’s priority is to ensure that you have the tools you need to care for your patients. Ranging from product kits to education opportunities, our Complete Solutions simplify preparation and streamline procedures to support quality patient care with a trusted, innovative range of medical devices.


BIOPSY

Biopsy Solution

We offer a wide range of reliable biopsy devices for precise samples every time. Our proven soft tissue biopsy brands, such as Achieve®, Temno®, Tru-Cut®, and CorVocet®, offer a complete selection with advanced features to obtain top-quality tissue samples with ease and efficiency.

LEARN MORE >

CARDIAC CATHETERIZATION

Our cardiac catheterization solutions provide you with a variety of tools to help you accurately diagnose and successfully treat patients with heart problems. From sheath introducers, like our Prelude IDeal™, and guide wires to catheters, inflation devices, and more, we offer a number of superior devices for your procedures.

LEARN MORE >

CRITICAL CARE

Critical Care Solutions

When treating vulnerable patients, every product you use matters. We offer a broad spectrum of tools designed for patients being treated in the critical care unit. Merit critical care technologies aim to reduce contaminant exposure, accurately monitor patient blood pressure, and decrease workplace injury, helping you provide treatment that is safe, effective, and efficient.

LEARN MORE >

DIALYSIS ACCESS

Dialysis Access Solution

Kidney disease is a global issue, and access is the foundation for any successful dialysis procedure. Our comprehensive dialysis access portfolio, including our catheter-dependence reducing HeRO® Graft, brings reliable and innovative solutions to your practice.

LEARN MORE >

PERITONEAL DIALYSIS

Our home dialysis options offer several patient advantages over in-center dialysis, including better kidney disease-related quality of life. We offer virtual and hands-on physician training, a wide range of catheter sizes, accessories, kits, and patient resources.

LEARN MORE >

RADIAL

Radial access has many well-documented benefits that include improved patient safety, a significant reduction in cost of care, and increased patient and staff satisfaction. We support radial access with a diverse portfolio of innovative products and a world-renowned hands-on physician education program, helping you offer the advantages of radial to your patients.

LEARN MORE >

DISTAL RADIAL ACCESS

Distal radial artery access offers both patient and operator advantages. To help bring these benefits to your practice, we provide advanced training on the distal technique as well as innovative products to support your procedures, such as the first-to-market PreludeSYNC DISTAL™ Radial Compression Device.

LEARN MORE >

DRAINAGE

Over the past two decades, we have continually expanded our drainage portfolio to include a diverse range of solutions that work together to help you achieve optimal drainage care. We offer multiple drainage catheters designed to lessen trauma and promote a more accurate placement.

LEARN MORE >

ELECTROPHYSIOLOGY & CRM

Successful diagnosis and treatment of electrical cardiac activity is crucial—this is why we offer a range of physician education courses and specialized tools to assist in making accurate diagnoses and create effective treatment plans. Features include extra-stiff transseptal needles, ergonomic handles for exceptional control, and advanced introducer systems.

LEARN MORE >

EMBOLOTHERAPY

Our proprietary embolic products are the most studied on the market and allow for efficient and safe delivery and predictable outcomes. To complement our offerings, we provide excellent ongoing customer service to ensure you have the tools you need for your procedures.

PROSTATIC ARTERY EMBOLIZATION
To help support your prostatic artery embolization (PAE) practice, we offer virtual and hands-on training, trusted products, clinical resources, patient materials, and more.


UTERINE FIBROID EMBOLIZATION
Our uterine fibroid embolization (UFE) solutions offer trusted products that deliver predictable clinical results as well as long-term symptom control.


We also offer extensive patient resources at our Ask4PAE and Ask4UFE sites.

LEARN MORE >

GASTROENTEROLOGY STRICTURE MANAGEMENT

GI Stricture Management

Merit Endoscopy’s fully covered, laser-cut esophageal stent technology provides for accurate placement and minimized migration. In addition to our state-of-the-art stent technology, we deliver best-in-class dilation products, including our BIG60® Inflation Device and our Elation dilation balloons as well as enhanced physician training.

LEARN MORE >

PULMONARY STRICTURE MANAGEMENT

For patients with tracheobronchial strictures, stent technology can provide rapid palliation and improve quality of life. We offer fully covered, laser-cut tracheobronchial stents and advanced over-the-wire and direct visualization delivery systems. Download case studies and participate in virtual and hands-on training—all designed to help you advance patient care.

LEARN MORE >

KITS & PACKS

Designed to bring convenience and efficiency to your office, our kits and packs solutions can help simplify prep and procedure, support quality patient care, and reduce inventory levels. Our team analyzed hundreds of kits and created a set of standard configurations that meet the needs of the majority of cath labs, interventional radiology, and vascular surgery departments. We also offer customizable kits to fit your unique procedural needs.

LEARN MORE >

SPINE

Through a diverse portfolio of sophisticated steerable technologies, we deliver complete procedural solutions designed to treat pathologies of the vertebrae, reduce pain, and improve patient quality of life. Our comprehensive education programs and unique products allow physicians to address patient-specific needs and physician preference in the treatment of vertebral pathologies.

LEARN MORE >

VENOUS

Venous Solutions from Merit Medical

Our minimally invasive venous solutions are designed to treat symptoms, minimize post-operative pain, and provide faster recovery. Explore products, accessories, and kits, packs, and trays—each complementing the next to provide you with better patient outcomes.

LEARN MORE >


Merit’s dedication to comprehensive customer care starts with providing the tools you need to treat your patients. Ready to get started? Available via email, phone, and live chat, our Customer Support team is here to help find a solution for you. Browse our virtual in-service and product support videos, all designed to help you obtain additional product knowledge and insights. We look forward to working with you.

Simplifying Patient Treatment with ReSolve ConvertX

ReSolve ConvertX® and Treatment of Biliary Obstructions in Pancreatic Cancer: A Physician’s Experience

Simplifying Patient Treatment with ReSolve ConvertXPancreatic cancer is the 12th most common cancer worldwide. In the US alone, approximately 60,430 people will be diagnosed with pancreatic cancer this year. Biliary obstructions are a common condition associated with pancreatic cancer. Patients with biliary obstructions often experience discomfort, such as abdominal pain, weight loss, nausea and vomiting, jaundice, and fever. Left untreated, biliary obstructions can lead to serious complications, including infection.

To help treat this patient population, Merit Medical offers the ReSolve ConvertX Biliary Stent System, a unique technology designed for temporary internal drainage in individuals with severe biliary obstructions.

The below case study and physician discussion presents successful treatment of a biliary obstruction with the ReSolve ConvertX in a patient with terminal pancreatic cancer.

CASE STUDY

Patient Profile: Elderly patient with terminal pancreatic cancer. Malignant tumor growth led to obstructions in the right and left hepatic ducts. Traditional bilateral biliary drains were placed to relieve symptoms of jaundice, infections, and abdominal pain.

Complications: Patient experienced frequent accidental pulling on the external portion of the drainage systems and returned to the interventional radiology department for multiple reinterventions. Lesions developed due to bile leakage through the existing track and irritating the skin. Patient also expressed that the two external bags were burdensome.

Procedure: Both biliary drains were removed over an Amplatz-style wire and were replaced with the ReSolve ConvertX Biliary Stent System. After both ReSolve ConvertX drains were in place, they were each converted, leaving only the stent portions in place.

Outcomes/Results: After placement, patient was happy with the treatment and able to experience relief and an improvement in quality of life.

Sample flouro of ReSolve ConvertX Biliary Stent Placement
Sample flouro of ReSolve ConvertX Biliary Stent Placement

Listen in as Mark H. LeQuire, MD, FACR, Diagnostic, Vascular & Interventional Radiologist at Montgomery Radiology Associates, discusses this case further in an in-depth interview.

ReSolve ConvertX Tip

  • When placing bilaterally, ensure both systems are in place before stent conversion. If the first drain is converted to a stent before the second one is in place, it increases the risk of dislodging the first stent while placing the second.

Learn more about the advantages the ReSolve ConvertX can offer your patients and practice by visiting the product page or contacting the Merit Customer Support Center.

ClariVein OC - treatment for endovenous mechanochemical ablation

ClariVein® OC 5-Year Follow-up Results: Good Occlusion Rate, No Major Complications

Chronic venous insufficiency (CVI) in the legs, also known as varicose veins, is a relatively common condition, with worldwide prevalence ranging between 10% and 30%. Varicose veins can result in a number of symptoms, including pain, leg swelling, itching, and skin discoloration. Individuals with the condition may experience diminished quality of life and loss of work productivity. Finding treatment options that are effective and comfortable for the patient have been an area of interest in the endovascular community. ClariVein OC - treatment for endovenous mechanochemical ablation

A study by researchers in Verona, Italy, found that endovenous mechanochemical ablation (MOCA) treatment with the ClariVein® OC Infusion Catheter was associated with a good occlusion rate, comparable with other techniques, including thermal techniques, without major complications. This is one of the first reports in literature for MOCA treatment of symptomatic varicose veins with 5-year results. With little long-term data pertaining to this type of treatment, the aim of the study was to evaluate long-term occlusion rates.

This retrospective single-center study was published in Journal of Vascular Surgery: Venous and Lymphatic Disorders. Mirandola et al. treated 395 primary, symptomatic, unilateral, incompetent varicose saphenous veins in an outpatient setting. Of these patients, none were treated bilaterally in the same session. The majority of vessels treated were great saphenous veins (92.3%), and the others were small saphenous veins. Procedures were performed with the ClariVein OC and polidocanol 2% in liquid form.

A total of 329 patients were available for follow up, each treated between September 2012 and September 2017. Average follow-up time was 20 ± 18 months (range, 6-60 months). Results showed a technical success of 99.5%. Treatment was incomplete in two patients due to vein spasm, leading to catheter damage and inability to infuse the sclerosant. Follow up consisted of clinical evaluation and duplex ultrasound scan performed at 1 week, 1 month, 6 months, 1 year, and then once every year.

The overall survival rate free from recanalization was 92.4%. Anatomic success was 94% at 1 year, 91% at 2 years, 88% at 3 years, 88% at 4 years, and 84% at 5 years. The follow up at 5 years included 23 patients, five of whom presented with recanalization. The authors note that in this series, the veins completely disappeared on duplex ultrasound scan in 36% of cases.

It is interesting to note that after 89 patients, the researchers changed the way in which the sclerosant was injected. Beginning the infusion of sclerosant at point of mechanical pullback (protocol 2) produced higher occlusion rates compared to traditional ClariVein OC technique (protocol 1) with delayed infusion of sclerosant. Protocol 2 resulted in a change in cumulative survival rate free from recanalization from 92% to 97% (P ¼ 0.013).

Difference in anatomic success between 2 different protocolsFig 4. Difference in anatomic success between the two different protocols.

The researchers concluded that the ClariVein OC was associated with a good occlusion rate and was comparable with other techniques, including thermal techniques, without major complications.

Varicose veins occur when vessels are unable to pump blood back to the heart, causing the blood to pool, resulting in vessel enlargement over time. Under normal conditions, blood moves from the heart to the legs through the arteries and back to the heart through the veins. To accomplish this, the veins rely on surrounding muscles and a collection of valves to prevent blood from flowing backward. When these muscles and valves weaken or fail to work, blood begins to gather in the vein instead of returning to the heart.

In addition to pain, swelling, itching, and skin discoloration, other symptoms of varicose veins include:

  • Twisted and bulging veins
  • Aching, burning, throbbing and muscle cramping
  • Leg heaviness and fatigue

The ClariVein OC alleviates these symptoms by combining the power of a specialty infusion catheter with a rotating wire tip designed for the controlled 360-degree dispersion of physician-specified agents inside the targeted vessel. Requiring only a pin-sized entry through the skin, treatment with the ClariVein OC takes very little time, uses no heat or tumescent anesthesia, and creates minimal discomfort to the patient.

Learn more about the clinically proven ClariVein OC and how it can change the lives of your patients. Visit ClariVein.com or contact our Customer Support for more information.


IMPORTANT: This product page is intended only for an audience outside of the United States, as ClariVein OC is not approved, cleared, or available for sale in the United States. This product is not approved, cleared, or available for sale or use in the United States, and may not be approved, cleared, or available for sale or use in other countries. Please check with your country representative to determine which ClariVein catheters are available in your country. Please consult the product Instructions for Use (IFU) for indications, contraindications, potential complications, warnings, precautions, and directions for use.

ARTICLE REFERENCED:

Mirandola M et al. 2020. “An Italian Experience with Mechanochemical Ablation of the Saphenous Vein Since 2012.” J Vasc Surg Venous Lymphat Disord 8, no 6 (Nov): 999–1005. PMID: 32179039.

One-Vac Evacuated Drainage Bottle - Merit Medical

Meet the One-Vac™, Merit’s Newest Evacuated Drainage Bottle

One-Vac Evacuated Drainage Bottle - Merit MedicalMerit Medical is proud to announce the launch of the One-Vac Evacuated Drainage Bottle, the latest in evacuated drainage bottle technology. The smart option to aspirate, remove, or sample percutaneous fluids, the One-Vac is engineered with an advanced design that makes collection and discard simple, efficient, and safe.

The One-Vac is a valued addition to Merit’s Drainage portfolio and accompanies other premier products, such as the Aspira® Drainage System. This extension of the Drainage portfolio is the result of Merit’s commitment to continued innovation and dedication to providing clinicians with multiple high-quality product options when treating patients.

Read the press release.

Several key features are designed to make the One-Vac easy to use, helping to reduce the occurrence of common issues associated with bottle use.

One-Vac Bottle has a number of design features that will provide lasting benefits to you and your patients

KEY FEATURES & BENEFITS

1 – Ergonomic Handle
Start, stop, and regulate flow. Easy to remove, minimizing spills during discard.

2 – Easy Sampling
Connect syringe and open handle to remove fluid for sampling.

3 – Bottle Neck
Easy to hold.

4 – Durable Plastic
Designed to prevent breakage.

5 – Faster Flow Rates
Provides 68% faster flow rates than competitive evacuated bottles.1

Learn more about the One-Vac Evacuated Drainage Bottle by exploring its product page or by connecting with our Customer Support Center to see how you can incorporate it and other Merit solutions into your practice today.


Before using, refer to the product Instructions for Use (IFU) for indications, contraindications, potential complications, warnings, precautions, and directions for use.

REFERENCES

1. Data on file.

Uterine Fibroid Embolization - Embosphere Microspheres

Embosphere® Results in Less Inflammatory Response, Lower Rates of Analgesic Use Compared to PVA After UFE

Every July, our team at Merit Medical recognizes Fibroid Awareness Month as a time to bring attention to a very common yet under-discussed condition that will affect most women at some point in their lifetime.

We do this by supporting a minimally invasive fibroid treatment called uterine fibroid embolization (UFE), also called uterine artery embolization (UAE), through a portfolio of embolotherapy products we offer.

Uterine Fibroid Embolization - Embosphere MicrospheresTo shed light on the performance of UFE embolic agents and to help physicians ensure women receive the best fibroid treatment experience possible, a randomized controlled trial by Han et al. compared post-UFE pain using nonspherical polyvinyl alcohol (PVA) particles versus Merit Medical’s Embosphere® Microspheres.

Published in Radiology, the study enrolled 54 women with fibroids (mean age, 44 ± 4 years [standard deviation]) and assigned UFE treatment with either nonspherical PVA (355–550 μm) or Embosphere (500–700 μm). There were 27 women in each group, and both participants and investigators collecting data were blinded to the embolic material used. Women with concomitant disease (e.g., adenomyosis) were excluded from the study.

Both groups were given fentanyl-based intravenous patient-controlled analgesia within the first 24 hours after UFE as well as rescue analgesics. The investigators measured neutrophil-to-lymphocyte ratio to assess inflammatory response, and contrast-enhanced MRI was performed 1 day after the procedure to evaluate dominant fibroid necrosis and ischemia of normal myometrium. Symptom severity score and health-related quality-of-life score were assessed before and 3 months after UFE.

Results showed that pain scores and fentanyl dose were not different during the first 24 hours, but the use of rescue analgesics was higher in the PVA group (33% vs 11%; P = 0.049). After embolization, symptom severity score and health-related quality-of-life score were not different between groups (symptom severity score: 16 [interquartile range, 6–22] for PVA vs 19 [interquartile range, 9–34] for Embosphere, P = .45; health-related quality-of-life score: 93 [interquartile range, 80–97] for PVA vs 89 [interquartile range, 84–96] for Embosphere, P = .41).

In addition, changes in neutrophil-to-lymphocyte ratio from before to 24 hours after UFE were greater in the PVA group (3.9 [interquartile range, 2.7–6.8] compared to the Embosphere group (2.5 [interquartile range, 1.5–4.6]; P = .02). Rates of complete dominant fibroid necrosis were not different between groups, but transient global uterine ischemia of normal myometrium was more frequent in the PVA group (44% vs 15%; P = .04).

The investigators of the study concluded that when used in UFE, PVA particles and Embosphere resulted in similar pain scores and fentanyl dose. However, PVA resulted in a greater inflammatory response, higher rates of rescue analgesic use, and more frequent transient global uterine ischemia compared to Embosphere.

Watch How UFE Works

Fibroids (also known as uterine fibroids, leiomyomas, and myomas) are non-cancerous tumors that grow within the muscle tissue of the uterus. Although some fibroids cause no symptoms at all, common symptoms can include excessive menstrual bleeding, pelvic pain and pressure, and frequent urination. Depending on the size and location of the fibroids, other symptoms can include anemia, leg pain, pain during sexual intercourse, constipation, and an enlarged abdomen. Up to 80% of women develop fibroids by the time they reach age 50.

Approximately, 600,000 hysterectomies are performed in the US each year, with fibroids listed as the most common reason. A report by the Society of Interventional Radiology found that 1 in 5 women believe hysterectomy is the only treatment option for fibroids and that 44% of women with fibroids have never heard of UFE. Although hysterectomy is a treatment for fibroids, there are many other treatment options available, many of which are minimally invasive.

44% of women have never heard of Uterine Fibroid Embolization

To encourage women to seek out all treatment options and help physicians educate patients, we offer an educational patient-awareness site called Ask4UFE with information about treatment options—with focus on UFE—as well as patient and physician testimonials and researched blog entries.

Join us in recognizing July as Fibroid Awareness Month. We look forward to working together to increase awareness surrounding the condition, helping to provide the best resources, products, and care for patients worldwide.


Before using, refer to Instructions for Use (IFU) for indications, contraindications, warnings, precautions, and directions for use.


ARTICLE REFERENCE
Han K et al. 2020. “Nonspherical Polyvinyl Alcohol Particles verusus Tris-Acryl Microspheres.” Radiology 298, no. 2 (Feb): 458–465. PMID: 33350893.

Merit Medical Brings Awareness to Men's Health

Merit Brings Awareness to Men’s Health During the Month of June

Merit Medical Brings Awareness to Men's HealthIt’s June and officially Men’s Health Month, a time dedicated to the raising awareness of health issues that affect men and boys, encouraging early detection and treatment of these conditions.

At Merit Medical, it’s our goal to not only provide the tools physicians need to treat and improve patient outcomes but also share knowledge and increase awareness surrounding risk factors for disease.

We understand that illness affects both men and women, but to offer the best patient care, it’s also important to shed light on diseases that are more prevalent in one sex versus the other.

Here are just some of the illnesses that are seen more frequently among men—and how we help care for each.

ESOPHAGEAL CANCER

Esophageal cancer is cancer found in the esophagus—the hollow, muscular tube in your body that carries food and liquid from the throat to the stomach. Men are around three times more likely than women to have esophageal cancer.

Esophageal CancerPrevention tips:

  • Avoid alcohol.
  • Eat more fruits and vegetables.
  • Maintain a healthy weight.
  • Exercise regularly.

Learn more about esophageal cancer.


MERIT PRODUCTS



LUNG CANCER

Lung cancer is a type of cancer that begins in the lungs. It is the leading cause of cancer deaths worldwide. The overall chance of a man developing lung cancer in his lifetime is approximately 1 in 15, whereas for a woman, the risk is about 1 in 17.

Lung Cancer Prevention TipsPrevention tips:

  • Quit smoking (or don’t start).
  • Stay away from secondhand smoke.
  • Test your home for radon.
  • Avoid cancer-causing chemicals.
  • Live a healthy lifestyle.

Learn more about lung cancer.


MERIT PRODUCTS



KIDNEY FAILURE

Although more women than men are diagnosed with chronic kidney disease, or CKD, men are more likely to reach kidney failure sooner.

Although kidney failure can happen to anyone, men may be more at risk compared to women due to differences in hormones and living unhealthier lifestyles.

Think Dialysis Access Merit Physician CoursePrevention Tips:

  • Get a kidney check-up at least every year.
  • Control your blood pressure and blood sugar.
  • Stop smoking (or don’t start).
  • Exercise and eat a healthy diet.
  • Maintain a healthy weight.
  • If you have an enlarged prostate, talk with your doctor to make sure it’s not blocking your urinary tract.
  • Give your doctor a list of any supplements, medicines, and/or hormone treatments you’re taking to ensure they aren’t damaging your kidneys.

Learn more about kidney failure and visit our Dialysis Access Solution page.


MERIT PRODUCTS



AORTIC ANEURYSM

The aorta runs from the heart through the center of the chest and abdomen. It’s the main blood vessel that brings blood to the abdomen, pelvis, and legs. An abdominal aortic aneurysm (AAA) is a life-threatening condition that occurs when the vessel enlarges, putting it at risk of bursting. Men are 4-15 times more likely to develop an AAA than women

Aortic AneurysmPrevention tips:

  • Stop smoking (or don’t start).
  • Reduce stress.
  • Exercise and eat a heart-healthy diet.
  • If you have diabetes or high blood pressure, take the medicines your doctor has prescribed.

Learn more about AAA. To learn more about our packs, wires, and other cardiac products, please visit our Merit Vascular page.


MERIT PRODUCTS



HEART ATTACK

heart attack, also known as a myocardial infarction, occurs when heart muscle doesn’t receive enough blood. As time passes without receiving treatment, the more damage is done to the heart. The main cause of a heart attack is coronary artery disease (CAD). Researchers have found that throughout life, men are about twice as likely as women to have a heart attack.

Heart Attack - Men's Health MonthPrevention Tips:

  • Eat a healthy diet.
  • Maintain a healthy weight.
  • Exercise regularly.
  • Stop smoking (or don’t start).
  • Monitor your cholesterol and blood pressure.
  • Manage your diabetes.
  • Take your prescribed medicines.

Learn more about heart attacks. Explore our Cardiac Portfolio, including our radial sheaths, catheters, wires, and compression devices.


MERIT PRODUCTS



LIVER CANCER

Hepatocellular carcinoma (HCC) is the most common type of primary liver cancer and is most often seen in people with chronic liver diseases, such as cirrhosis caused by hepatitis B or hepatitis C. Worldwide, HCC is the fourth leading cause of cancer death and is 3 times more common among males than females.

Liver Cancer - Men's Health MonthPrevention Tips:

  • Avoid heavy alcohol use.
  • Reduce exposure to aflatoxin B1.
  • Stop smoking (or don’t start).
  • Get the hepatitis B vaccine.
  • If you have hepatitis, work with your care provider to receive treatment.

Learn more about liver cancer. Visit our Hepatic Oncology portfolio.


MERIT PRODUCTS



BENIGN PROSTATIC HYPERPLASIA (BPH)

Benign prostatic hyperplasia, or BPH, is the enlargement of the prostate gland and affects only men. It becomes more common as men get older. Up to 90% of men over the age of 80 have BPH. Although BPH is noncancerous, it can cause bothersome lower urinary tract symptoms.

BPH - Men's Health MonthPrevention Tips:

  • Maintain a heart-healthy diet.
  • Avoid heavy alcohol use.
  • Exercise regularly.

Explore the products we offer to support prostatic artery embolization (PAE), a minimally invasive option to treat BPH.


MERIT PRODUCTS



At Merit Medical, our goal is to improve the lives of people, families, and communities worldwide. An important part of this is caring for men’s health by providing the products and therapies needed for patients to live at their best.

Have questions? Reach out to our Customer Support team.


Before using, refer to Instructions for Use for indications, contraindications, warnings, precautions, and directions for use.

Merit Medical Exhibiting New Products & Education at SIR 2021

Merit Medical to Exhibit New Products and Must-See Educational Symposia During SIR 2021

National Kidney Month

Merit Recognizes National Kidney Month & World Kidney Day

SplashWire - It's Time to Reimagine Your Guide Wire

New SplashWire™ Delivers Superior Performance in Diagnostic and Interventional Procedures

ClariVein OC - Treatment for Varicose Veins - Outside US Only

ClariVein® OC Provides Varicose Vein Relief, Less Pain Than Radiofrequency Ablation, Similar Quality of Life Outcomes

SwiftNINJA Steerable Microcatheter - Merit Medical

SwiftNINJA® Overcomes Challenges of Selective Catheterization

WRAPSODY™ Inhibits Cell Migration, Tissue Accumulation Across Graft Layers, Helping to Maintain Vessel Patency

Surfacer Now Available In the United States - Merit Medical

Now Available in the US, Surfacer® System Provides Treatment Option for Venous Obstructions

Merit Medical® is committed to offering products that provide patients with better dialysis access options. The newest of these innovations is the Surfacer® Inside-Out® Access Catheter System, a unique device designed to obtain right-sided central venous access in patients with venous obstructions. The Surfacer System received FDA De Novo classification in the US earlier this year and has been CE marked in Europe since 2016.

The current clinical approach when treating dialysis patients with chronically occluded central veins is to use another vein if a subsequent central venous catheter is needed. Failed venous access attempts may prevent permanent arteriovenous access, increasing patient morbidity and the overall cost of care.1

Designed to gain central venous access, the Surfacer System works by inserting the device through the right femoral vein and navigating it up through the patient’s venous system with an exit point in the right internal jugular vein, the optimal location for placing a central venous catheter. Watch how the Surfacer System works.

This proprietary “Inside-Out” approach supports the achievement of permanent arteriovenous access, which reduces hemodialysis provider cost and patient downtime by decreasing catheter-related morbidity and complications.1

Additional clinical benefits of using the Surfacer System were seen in its first-in-human study.2 Results showed that 100% of patients experienced successful central venous access placement, and 100% of patients maintained central venous access patency through long-term follow up. No device-related adverse events were reported at short- or long-term follow up. To learn more about the Surfacer System’s first-in-human study, view the article published in Endovascular Today.

In May of this year, the Surfacer System’s first US-based commercial cases were completed at Santa Clara Valley Medical Center in San Jose, California, one of several clinical sites for the US investigational device exemption (IDE) study, which led to FDA De Novo status. Ehab Sorial, MD, and Ajit Nair, MD, performed the procedures in two hemodialysis patients with central venous obstructions, one of which had limited access options.

“The Surfacer System provides us with a safe and effective option for obtaining right-sided central venous access in patients with venous obstructions, enabling us to preserve secondary central veins and avoid alternative access procedures, which are not as effective and have a higher risk of complications,” explained Drs. Sorial and Nair in a press release. Read the full press release here.

Merit currently distributes the Surfacer System in North America and Europe. With the device’s recent launch in the US, Merit is proud to play an integral role in providing physicians with life-saving technologies for their patients around the world.

Discover the Surfacer Inside-Out Access Catheter System and explore Merit’s entire portfolio of renal therapies and accessories.

 

All trademarks are property of their respective owners.


REFERENCES

  1. Data on file at Bluegrass Vascular Technologies, Inc.
  2. Ebner, A., S. Gallo, C. Cetraro, J. Gurley, and L. Minarsch. 2013. “Inside-Out Upper Body Venous Access: The First-in-Human Experiences with a novel Approach Using the Surfacer Inside-Out Access Catheter System.” Endovascular Today. June 2013. https://evtoday.com/articles/2013-june/inside-out-upper-body-venous-access.

Merit Medical Launches GO2WIRE™ Steerable Guide Wire System

New Steerable Guide Wire Offers Physicians a Number of Desirable Features, Making it the New “Go-To” Wire for Diagnostic and Interventional Procedures.

Merit Medical® is proud to announce the official market launch of the GO2WIRE™ Steerable Guide Wire System, a wire designed to facilitate the placement and exchange of devices during peripheral diagnostic and interventional procedures. Built with a number of key features, the GO2WIRE helps physicians confidently navigate the most challenging vasculature.

AVAILABLE IN THREE TIP CONFIGURATIONS

GO2 Wire - Floppy Straight Tip Configuration - Merit Medical
GO2 Wire - Intermediate J Tip Configuration - Merit Medical
GO2 Wire - Standard Straight Tip Configuration - Merit Medical

Available in three tip configurations—Floppy Straight, Intermediate J, and Standard Straight—the GO2WIRE offers both support and flexibility when accessing complex anatomy. Engineered with Straight Linear Torque Steel Core Wire technology, data1 shows the GO2WIRE has a 40% tip response improvement over the leading competitor. The GO2WIRE’s distal tip is reshapable, providing physicians with the ability to modify the wire tip to meet specific anatomical needs. Enhanced with platinum, the tip provides excellent visibility under fluoroscopy.

TWO BODY STYLES

To further help physicians traverse tortuous vessels, the GO2WIRE is also available in two body styles—non-extendable and extendable—with the largest range of length options offered in the market. As an advocate of radial access, Merit designed the GO2WIRE with an exclusive 210 cm length configuration specifically designed for radial access procedures. In addition, the GO2WIRE provides an optional 155 cm extension device with smooth threads, a modification that helps deliver rapid conversion to longer wire lengths for seamless device and catheter exchanges. The GO2WIRE also has a proprietary PTFE pre-coating to help reduce friction and improve trackability.

Procedural Opportunities Offer Enhanced Navigation or Exchanges - GO2 Steerable Guide Wire - Merit Medical
The launch of the GO2WIRE Steerable Guide Wire System expands Merit’s current offering of guide wires, allowing the company to provide a more comprehensive guide wire portfolio with several advantages over other systems on the market today. By providing physicians with complete product solutions, Merit continues to fulfill its mission of improving lives around the globe.

Explore the GO2WIRE Steerable Guide Wire System.


1. Data on file.

The Aspira® Advantage, Transforming Home Drainage into Compassionate Care

The Aspira® Advantage, Transforming Home Drainage into Compassionate Care

Merit Medical® products and services ensure that patient care is compassionate care. The Aspira® Home Drainage System—a palliative care product designed to help patients with malignant pleural effusions and ascites drain fluid in the comfort of their own home—is a prime example. With the help of Aspira, patients can manage symptoms without repeated and often difficult trips to the hospital. Combined with 24/7 ongoing support from an expert customer service team, the Aspira system gives patients a gentler and more efficient approach to home drainage. All this and more is what Merit likes to call the Aspira Advantage.

It starts with a superior product, the Aspira Home Drainage System, which features a 15.5F indwelling catheter with attachable valve made to drain accumulated fluid into lightweight, 1-liter bags. To begin draining, the Aspira system requires no complex set up; the drainage line connects easily to the drainage bag, and with one gentle squeeze of the pump, drainage begins.

Built to enhance the patient experience, the Aspira system minimizes discomfort and challenges that can often be associated with drainage. Its gravity-based design produces a low, consistent vacuum pressure flow, which can reduce pain seen with high-vacuum suction methods of other systems.

Simulated testing1 shows that with 67% more fenestrations and a 72% larger valve, the Aspira system can comfortably complete drainage in less than 15 minutes—68% faster than other systems—and all within the comfort of home.

Choosing Aspira means benefits to the physician as well, including product options that increase flexibility of patient care. The Aspira system is designed with three different placement options (antegrade, retrograde, and over-the-wire) and various kit configurations to accommodate patient and customer needs.The Aspira® Advantage, Transforming Home Drainage into Compassionate Care

Switching from hospital drainage to home drainage with the Aspira system is also cost effective in many ways. Aspira bags are less bulky, and they are easier to transport and store in homes, hospitals, and post-care facilities. Comparative data1 show that one box of four bottles and dressings require approximately the same space as 20 Aspira bags and dressings, or 68% less storage space.

Another advantage to choosing the Aspira system is the ongoing customer service that Merit offers patients and providers. The Compassionate Care Program supports patients with Aspira supplies, delivered right to their homes, even for those without health insurance.

In-servicing and home health training is available as well as opportunities for written feedback on the Aspira system, flexibility in shipping, and assistance with reimbursement. Print and online educational materials are available at MyAspira.com, a site tailored to both patients and providers. If patients or customers want one-on-one help, a highly trained customer service team is ready to assist 24/7 through the dedicated Aspira Hotline (1-800-356-3748).

Let Merit help you transform home drainage into compassionate care with the Aspira Advantage. Explore everything it can offer by visiting MyAspira.com, or reach out to the customer service team today to receive a patient demo kit and hear more about the training opportunities it provides.

Learn more about the product, including its instructions for use and important product safety information, by visiting the Aspira Drainage System product page.


REFERENCES

  1. Data on file.
ReSolve ConvertX Limits Risk Exposure for Your Patients - Merit Medical - Stent Systems

ReSolve ConvertX® Simplifies Drainage Care, Limits Patient Exposure

ReSolve ConvertX Limits Risk Exposure for Your Patients - Merit Medical - Stent Systems

To limit coronavirus exposure to patients and healthcare workers, healthcare facilities are decreasing the number of procedures performed as well as the length of procedure time for those that remain scheduled. This includes replacing surgical care with less-invasive interventional radiology procedures.

New hospital protocols may prove challenging for patients who need multistep care, as seen with individuals who suffer with severe ureteral or biliary obstructions. Traditionally, these patients require two separate interventional procedures to successfully place a temporary internal drainage: a first procedure to place a drainage catheter and a second to place a stent.

To simplify treatment for these patients, Merit Medical offers a temporary internal nephroureteral and biliary drainage stent system called the ReSolve ConvertX Stent System. A less-invasive option than conventional treatment, the ReSolve ConvertX completely eliminates the need for a second drain-to-stent procedure. Instead, stent conversion can be done in an office or at bedside in less than one minute.1

 

ReSolve ConvertX - Minimally Invasive, Reduces Patient and Provider Risk, Limits Exposure - Merit Medical

WATCH HOW THE RESOLVE CONVERTX WORKS

Simplifies Treatment - Resolve ConvertX

Eliminating a second interventional procedure has several advantages, particularly in the present healthcare crisis. Without the need for a lengthy, additional drain-to-stent procedure, hospital visits may be shorter for patients,2 potentially resulting in less risk of exposure to other patients, physicians, and hospital staff. Because treatment with the ReSolve ConvertX can be completed in a less-intense care setting, it can free up physicians and hospital staff to care for an increasing caseload outside of the interventional radiology suite. This may also leave the interventional radiology suite open for an influx of new interventional cases.

Reduces Exposure - Resolve ConvertX

The ReSolve ConvertX is also designed with other clinical benefits in mind, such as reduced procedural challenges for the patient. Furthermore, with fewer procedures, there is less radiation exposure for patients, physicians, and hospital staff.

FIRST IMPRESSIONS OF RESOLVE CONVERTX

Evolving Embolotherapy at Merit with Modernized Gelatin Foam - Understand. Innovate. Deliver.

Merit Modernizes Gelatin Foam with Torpedo™ and EmboCube™ Embolotherapy Products

Merit Medical has a strong history of delivering high-quality embolics. For decades, our extensive embolotherapy portfolio has brought our customers a comprehensive line of clinically proven products made to streamline embolization procedures. Our embolotherapy offerings include a broad range of microspheres as well as nonspherical polyvinyl alcohol particles and gelatin foam products. A recent addition to our portfolio is the Torpedo, a new proprietary gelatin foam product indicated for the embolization of hypervascular tumors and bleeding in the peripheral vasculature. Along with EmboCube, another of our premium gelatin foam embolic agents with the same indications, our product offerings modernize preparation and delivery of gelatin foam by enabling speed, precision, and consistency.


SPEED

Torpedo and EmboCube were created to address preparation concerns associated with using traditional gelatin foam sheets. By making gelatin foam use faster, easier, and more efficient, physicians are able to focus more on the patient. To save physicians valuable time, Torpedo and EmboCube products only require hydration with a 50:50 saline-to-contrast mixture. Particles come uniformly cut, the Torpedo in a cylindrical shape and EmboCube in cubes, and both are preloaded, the Torpedo into a cartridge and EmboCube into a syringe. By eliminating the need for manual foam cutting, shaping, and loading into a delivery system, preparation is simplified when using Torpedo and EmboCube gelatin foam products.


PRECISION

Another challenge with manually cutting and shaping gelatin foam is that it results in inconsistently sized particles. Torpedo and EmboCube are available in two uniformly pre-cut sizes (2.5 mm and 5.0 mm diameters) and are designed for use with compatible catheters and microcatheters with inner diameters large enough to deliver the embolic material. These standardized sizes allow physicians to match the vasculature and achieve targeted embolization.


CONSISTENCY

Standardized particle sizes not only aid in achieving targeted embolization but also assist in proactively eliminating delivery challenges, such as particle aggregation in the catheter lumen. Inconsistently sized particles run the risk of clogging the delivery catheter. On the contrary, calibrated embolic particles, such as Torpedo and EmboCube gelatin foam, facilitate smooth catheter passage, helping to provide consistent and predictable results. Biocompatible and resorbable, Torpedo and EmboCube provide temporary yet durable mechanical occlusion.


Torpedo and EmboCube demonstrate Merit Medical’s commitment to ongoing innovation in the embolotherapy field. Providing safety, efficiency, and value to our embolotherapy customers enables them to reduce procedural time without compromising quality care.

Learn more about Torpedo and EmboCube gelatin foam products and explore our entire embolotherapy portfolio.

Please consult the product labels and inserts for any indications, contraindications, potential complications, warnings, precautions and directions for use.